SAREPTA THERAPEUTICS INC (SRPT) Stock Analyst Ratings
NASDAQ:SRPT - US8036071004 - Common Stock
17.84 USD
-0.22 (-1.22%)
ChartMill assigns a Buy % Consensus number of 67% to SRPT. The Buy consensus is the weighted average rating of the current analysts ratings.
Analysts have set a mean price target forecast of 33.58. This target is 88.23% above the current price.
SRPT was analyzed by 36 analysts. The buy percentage consensus is at 67. So analysts seem to be have mildly positive about SRPT.
In the last month the buy percentage fell by 9 points. So the trust of analysts is decreasing.
SRPT was analyzed by 36 analysts, which is quite many. So the average rating should be quite meaningful.
Price Target & Forecast
| Date | Firm | Action | Rating |
|---|---|---|---|
| 2025-08-25 | HC Wainwright & Co. | Reiterate | Sell -> Sell |
| 2025-08-21 | B of A Securities | Maintains | Underperform -> Underperform |
| 2025-08-20 | B of A Securities | Maintains | Underperform -> Underperform |
| 2025-08-15 | Deutsche Bank | Maintains | Sell -> Sell |
| 2025-08-07 | Wells Fargo | Maintains | Overweight -> Overweight |
| 2025-08-07 | Goldman Sachs | Maintains | Neutral -> Neutral |
| 2025-07-30 | Barclays | Upgrade | Underweight -> Equal-Weight |
| 2025-07-29 | Bernstein | Initiate | Market Perform |
| 2025-07-29 | BMO Capital | Maintains | Market Perform -> Market Perform |
| 2025-07-29 | Needham | Reiterate | Underperform -> Underperform |
| 2025-07-29 | Oppenheimer | Upgrade | Perform -> Outperform |
| 2025-07-29 | Barclays | Upgrade | Underweight -> Equal-Weight |
| 2025-07-29 | JP Morgan | Upgrade | Underweight -> Neutral |
| 2025-07-29 | Morgan Stanley | Maintains | Equal-Weight -> Equal-Weight |
| 2025-07-29 | Piper Sandler | Maintains | Neutral -> Neutral |
| 2025-07-28 | Needham | Reiterate | Underperform -> Underperform |
| 2025-07-25 | JP Morgan | Downgrade | Neutral -> Underweight |
| 2025-07-24 | Wells Fargo | Maintains | Overweight -> Overweight |
| 2025-07-24 | Citigroup | Initiate | Sell |
| 2025-07-24 | Jefferies | Maintains | Buy -> Buy |
| 2025-07-23 | B of A Securities | Downgrade | Neutral -> Underperform |
| 2025-07-22 | BMO Capital | Maintains | Market Perform -> Market Perform |
| 2025-07-22 | Needham | Reiterate | Underperform -> Underperform |
| 2025-07-22 | Barclays | Downgrade | Overweight -> Equal-Weight |
| 2025-07-22 | Piper Sandler | Maintains | Neutral -> Neutral |
| 2025-07-21 | Leerink Swann | Downgrade | Outperform -> Market Perform |
| 2025-07-21 | Mizuho | Downgrade | Outperform -> Neutral |
| 2025-07-21 | BMO Capital | Maintains | Market Perform -> Market Perform |
| 2025-07-21 | UBS | Downgrade | Buy -> Neutral |
| 2025-07-21 | Needham | Downgrade | Hold -> Underperform |